Updating the OMERACT filter: discrimination and feasibility

George Wells; Dorcas E Beaton; Peter Tugwell; Maarten Boers; John R Kirwan; Clifton O Bingham 3rd; Annelies Boonen; Peter Brooks; Philip G Conaghan; Maria-Antonietta D'Agostino; Maxime Dougados; Daniel E Furst; Laure Gossec; Francis Guillemin; Philip Helliwell; Sarah Hewlett; Tore K Kvien; Robert B Landewé; Lyn March; Philip J Mease; Mikkel Ostergaard; Lee Simon; Jasvinder A Singh; Vibeke Strand; Désirée M van der Heijde

doi:10.3899/jrheum.131311

Updating the OMERACT filter: discrimination and feasibility

J Rheumatol. 2014 May;41(5):1005-10. doi: 10.3899/jrheum.131311. Epub 2014 Apr 1.

Affiliation

¹ From the Cardiovascular Research Methods Centre, Department of Epidemiology and Community Medicine, University of Ottawa; Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; Departments of Epidemiology and Biostatistics, and Rheumatology, VU University Medical Center, Amsterdam, The Netherlands; University of Bristol Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Occupational Sciences and Occupational Therapy, Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center and Caphri Research Institute, Maastricht University, Maastricht, The Netherlands; Australian Health Workforce Institute (AHWI), School of Population Health, University of Melbourne, Melbourne, Australia; Division of Musculoskeletal Disease, University of Leeds, and UK National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK; Versailles-Saint Quentin En Yvelines University, Department of Rheumatology, Ambroise Paré Hospital, APHP, Boulogne-Billancourt; Paris-Descartes University, Medicine Faculty, APHP, Cochin Hospital, Rheumatology B, Paris, France; Section of Rheumatology, Cardiff University School of Medicine, Cardiff, UK; Department of Rheumatology, Geffen School of Medicine at the University of California in Los Angeles; Los Angeles, California, USA; Université Pierre et Marie Curie (UPMC) - Paris 6, GRC-UMPC 08 (EEMOIS); AP-HP Pitié Salpêtrière Hospital, Department of Rheumatology, Paris; Université de Lorraine, Université Paris Descartes, Nancy, France; University of Leeds, Section of Musculoskeletal Disease, LIMM Chapel Allerton Hospital, Leeds West Yorkshire; University of the West of England, Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK; Department of Rh

Abstract

The "Discrimination" part of the OMERACT Filter asks whether a measure discriminates between situations that are of interest. "Feasibility" in the OMERACT Filter encompasses the practical considerations of using an instrument, including its ease of use, time to complete, monetary costs, and interpretability of the question(s) included in the instrument. Both the Discrimination and Reliability parts of the filter have been helpful but were agreed on primarily by consensus of OMERACT participants rather than through explicit evidence-based guidelines. In Filter 2.0 we wanted to improve this definition and provide specific guidance and advice to participants.

Keywords: DISCRIMINATION; FEASIBILITY; OUTCOME AND PROCESS ASSESSMENT; OUTCOME MEASURES IN RHEUMATOLOGY.

Publication types

Consensus Development Conference

MeSH terms

Discrimination, Psychological
Evidence-Based Medicine / standards
Feasibility Studies
Humans
Outcome and Process Assessment, Health Care / standards*
Outcome and Process Assessment, Health Care / trends*
Rheumatic Diseases / classification*
Rheumatic Diseases / therapy*
Rheumatology / standards*

Updating the OMERACT filter: discrimination and feasibility

Authors

Affiliation

Abstract

Publication types

MeSH terms

Grants and funding